Search Results

GPCR Ecosystem #GPCR #DrGPCR #Pharma #Biotech #Research Published on March 15, 2025 Category Dr. GPCR Ecosystem #GPCR #DrGPCR #Pharma #Biotech #Research Previous Next Recent Articles

GPCR location within the cell can change everything: function, pharmacology, and even drug response. 🎙️ Listen now https://buff.ly/fYZ1tSq #DrGPCR #GPCR #DrugDiscovery #Pharma #Biotech #SciencePodcast GPCR location within the cell can change everything: function, pharmacology, and even drug response. 🎙️ Listen now https://buff.ly/fYZ1tSq #DrGPCR #GPCR #DrugDiscovery #Pharma #Biotech #SciencePodcast

Join GPCR Happy Hour to connect with scientists across academia, biotech, and pharma - a free networking Cross-sector : Academia, biotech, pharma, CROs all in one room.

✨ We've poured our passion for pharmacology into creating this essential resource, designed to meet you Ready to: Strengthen your pharmacology fundamentals? Terry's Corner helps you make better decisions through better pharmacology. Enroll now: https://www.terrykenakin.com #pharmacology #GPCRscience #drugdiscovery #TerrysCorner #biotechtraining #ScienceEducation #Pharma #GPCR #DrGPCR Previous Next Recent Articles

GPCR was created to break down barriers across academia, biotech, pharma, and CROs—so knowledge, tools including: Academic researchers (PI, postdoc, student) Industry scientists and R&D leaders Biotech and pharma

Evi Kostenis "Pharmacist by training - PhD in Pharmacology - Postdoc at the NIH with Dr. Juergen Wess - Postdoc and Group leader in Aventis, now Sanofi, Frankfurt, Germany - Head of in vitro Pharmacology at 7TM Pharma in Denmark; Full professor, department chair and director of the institute for pharmaceutical

GPCR Ecosystem, with the goal is to bring together GPCR scientists, biotech, and pharma leaders as well

more than 25 years of experience in drug development. have been engaged in GPCR cellular and clinical pharmacology I have participated and initiated methodologies for development of pharmacologically active anti-GPCR have published or contributed in 38 published scientific work mainly in the field of immunology and pharmacology creation of Inoviem scientific in Nov. 2011 by myself we have been regularly working with GPCRs for our pharma

other indications including non-alcoholic steatohepatitis (NASH) and inflammatory diseases and Keltic Pharma

The vehicle by which Andrew is translating fundamental findings to commercial products is Keltic Pharma

He then moved to the National Institute of Mental Health, researching pharmacological mechanisms of Class analysis company supporting pharmaceutical, life science, and academic scientists in the development As an industry pharmacologist, he consults with numerous pharma and biotechs in understanding and applying in vitro pharmacology data to advance drug discovery. Hoare was a pharmacology leader in the pharmaceutical industry for 15 years at Neurocrine Biosciences

Prior to his role at Addgene, Jason held roles in academia, big pharma, and non-profit research organizations

Discover what 40+ years of pharmacology reveal. Terry’s Corner was built to make advanced pharmacology practical: a space where scientists don’t just Pharmacologists are almost always working in systems they don’t fully understand. ✳️ Next AMA Session: October 30 | 12–1 PM EST #GPCR #DrGPCR #Pharmacology #DrugDiscovery #AllostericModulation #Kinetics #AssayDevelopment #EarlyDiscovery #PharmaR&D #BiotechInnovation Previous Next Recent Articles

Level up your pharmacology toolkit. 1 Ask-Me-Anything Session - Sept 18 - Trailer Published on October 28, 2025 Category Terry's Corner Pharmacology early—before your program locks into costly pathways Rethink legacy screening frameworks through modern pharmacology #GPCR #DrGPCR #Pharmacology #DrugDiscovery #Biotech #AllostericModulation #Kinetics #AssayDevelopment #EarlyDiscovery #PharmaR&D #BiotechInnovation Previous Next Recent Articles

Dmitry Veprintsev , a molecular pharmacologist at the University of Nottingham, to discuss his scientific Biotech – The unexpected journey into biotech entrepreneurship, providing GPCR profiling services to pharma Summary made with AI About Dmitry Veprintsev Dmitry is Professor of Molecular and Cellular Pharmacology at the Paul Scherrer Institute and ETH Zürich in Switzerland, changing his attention to structural pharmacology 2021 he co-founded Z7 Biotech, developing and providing innovative GPCR drug screening and precision pharmacology

of the Faculty of Pharmacy & Pharmaceutical Sciences, Monash University, Australia. In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr. Pharmaceutical Industry Experiences and GPCR History Arthur shared his experiences in the pharmaceutical industry, highlighting the differences between big pharma and biotech. Arthur recounted a 2004 visit to a pharma company using replicates in assays.

Podcast Strategic Partners Inês Pinheiro, Monserrat Avila Zozaya & Yamina Berchiche About Inês Pinheiro PharmD As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and

Randy Hall Randy Hall, Ph.D., is a Professor of Pharmacology and Chemical Biology in the Emory University Randy has received a number of research prizes, including the PhRMA New Investigator Award, the Distinguished

Development department, leading her team on the development of innovative HTRF™ and AlphaLISA™ kits for pharma She has been leading collaborative projects with public research institutes and pharmaceutical companies HTRF technology and accelerate the company’s reagents use in academic labs, biotech companies, and pharma

Everyone is welcome to present their work (students, postdocs, PI's, biotech, pharma companies)!

Who We Are We are a global network of scientists, biotech innovators, pharma professionals, CRO leaders fundraising or due diligence Expert Contributors Include: ✔ Terry Kenakin, with his exclusive series on GPCR pharmacology

Maria Waldhoer "I am a pharmacologist with a ~30 years background in academia and industry, working both in big pharma and biotech settings. Trejo joined the faculty in the Department of Pharmacology at the University of North Carolina in 2000 and then moved to UC San Diego School Medicine, Department of Pharmacology in 2008, where she quickly In 2014, she was appointed Vice-Chair of the Department of Pharmacology. The long-term goal of Dr.

in a competitive manner and in a short time (<3 months), customized fluorescent ligands with optimal pharmacological Maria Majellaro earned her degree in Pharmaceutical Chemistry and Technology from the University of Bari and completed her PhD in Biomolecular Sciences in Pharmacology and Medicine as “Doctor Europeus” in work focuses on organic synthesis, medicinal chemistry, and the development of GPCR-targeted tools for pharma Probes Innovative fluorescent probes that de-risk the pre-clinical drug discovery phase with optimal pharmacological

as a PhD project has grown into a commercial technology that helps scientists interrogate receptor pharmacology The company works with clients from pharma, CROs, and academia, including MD Anderson and several leading Maria Majellaro obtained her PhD with the distinction of Doctor Europeus from the Department of Pharmacy

He joined Mount Sinai through FlexMed — bypassing the MCAT — and was torn between a career in pharma equally focused on sex differences in pain processing and the failure of "one-size-fits-all" models in pharmacology Other academic interests of his include studying pharmaceutical finance & healthcare administration and

Sabbagh was recruited by Vertex Pharmaceuticals (Canada) where he worked on biomarker discovery for inflammatory drug discovery of small molecules for the treatment of inflammatory disorders and cancer at Paraza Pharma Department of Pharmacology-Physiology, Université de Sherbrooke, Sherbrooke, Quebec, Canada 2. Université Claude Bernard - Lyon, Faculté de Pharmacie, Lyon, France 4. Our research aims to leverage this knowledge to identify novel pharmacological targets and contribute

She is also very active within the pharmacology community and currently serves on the editorial board of the British Journal of Pharmacology. Given her expertise in GPCR pharmacology and scientific communication, she is poised to make valuable Inês Pinheiro PharmD by training and Ph.D. candidate in Hartley's lab at the University of Geneva. Biology and Pharmacology from Monash University.

accelerate your pipeline Book My Consultation Critical Bottlenecks in Your GPCR Pipeline ❌ Overwhelming pharmacology Actionable Scientific Validation: Ensure target companies execute the right GPCR pharmacology experiments Showcase your specialized GPCR expertise to stand out from competitors and attract high-value biotech and pharma With over two decades dedicated to GPCR pharmacology across biotech, academia, and the non-profit sector Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution

GPCR Drug Discovery Gain insider methods from the pioneers shaping biased signaling, assay design, and pharmacology—skills Terry Kenakin Terry's Corner Author of 'A Pharmacology Primer', the definitive GPCR reference used by Sam Hoare Pharmechanics GPCR signaling & biased agonism expert regularly consulted by top pharma companies Pioneer in quantitative pharmacology methods. Dr. Yamina Berchiche Dr. Also super-valuable for those of us learning how to teach pharmacology Anonymous Dr.

Welcome to Flash News—your fastest track to the latest updates in GPCR research, pharmacology, and biotechnology Pharmacologists are almost always working in systems they don’t fully understand. #Kinetics #AssayDevelopment #EarlyDiscovery #PharmaR&D #BiotechInnovation Ask-Me-Anything Session - #EarlyDiscovery #PharmaR&D #BiotechInnovation Irreversible kinetics = strategic lever in drug design October 27, 2025 Terry's Corner Read full article Receptor pharmacology has evolved.